| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of SSR2 mRNA | decreases expression | 12958071
|
| D016718 |
Arachidonic Acid |
Arachidonic Acid results in decreased expression of SSR2 mRNA | decreases expression | 16623957
|
| C099555 |
CD 437 |
CD 437 results in decreased expression of SSR2 mRNA | decreases expression | 12958071
|
| D016572 |
Cyclosporine |
Cyclosporine results in increased expression of SSR2 mRNA | increases expression | 20106945
|
| D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of SSR2 mRNA | decreases expression | 18042831
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of SSR2 mRNA | increases expression | 17942748 17555576
|
| D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SSR2 mRNA | affects cotreatment|increases expression | 17942748
|
| D016627 |
Oxidopamine |
Oxidopamine results in increased expression of SSR2 mRNA | increases expression | 12486162
|
| D008628 |
Mercury |
Mercury results in decreased expression of SSR2 mRNA | decreases expression | 16823088
|
| C041786 |
palm oil |
palm oil results in decreased expression of SSR2 mRNA | decreases expression | 18042831
|
| C009277 |
sodium arsenate |
sodium arsenate results in increased expression of SSR2 mRNA | increases expression | 16882884
|
| D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of SSR2 mRNA | increases expression | 18175754
|
| D013629 |
Tamoxifen |
Tamoxifen affects the expression of SSR2 mRNA | affects expression | 17555576
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SSR2 mRNA | affects cotreatment|increases expression | 17942748
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.68 | 14745880 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.96 | 11752688 14514962 15322242 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.08 | 17505938 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.83 | 14692618 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.49 | 16835633 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.02 | 11748828 |
| MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
10.26 | 15238619 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
10.26 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.71 | 15885639 |
| MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Oxidopamine |
4.71 | 14699433 |
| MESH:D001321 |
Autistic Disorder |
|
Arachidonic Acid |
2.73 | 18582451 |
| MESH:D001321 |
Autistic Disorder |
|
Mercury |
2.73 | 17497416 |
| MESH:D001327 |
Autoimmune Diseases |
|
Mercury |
4.98 | 16634805 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.12 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.81 | 15746008 |
| MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
1.83 | 20435547 |
| MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.83 | 16273361 19189210 18997820 20390343 16818667 20005174 18629630 21138602 18855134 17049068 11161223 16873071 19103187 15565566 18351453 20859285 17893378 17261762 18815881 19115204 19289846 19189212 20135344 20544844 19084267 19487384 19066611 19200415 19155303 17440819 19059307 19288272 19142967 19410462 15668708 21152245 19221464 18984771 20065188 19011961 17242785 16202921 19244106 18425577 18821012 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.83 | 20435547 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.86 | 16835633 |
| MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.61 | 19066611 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
1.83 | 16924424 |
| MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.69 | 17572228 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.41 | 18670907 18850075 16120746 |
| MESH:D002311 |
Cardiomyopathy, Dilated |
|
Mercury |
3.48 | 10334427 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.58 | 12371664 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.23 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.98 | 19486331 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.98 | 17110522 11677210 16105132 16919318 17681005 17333356 15861022 |
| MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.86 | 15894690 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.13 | 16354765 12621046 15668235 8697196 15340226 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 14669216 17141729 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
sodium arsenate |
2.80 | 10525206 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.80 | 15322242 20055451 10048152 |
| MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.47 | 19031437 |
| MESH:D017449 |
Dermatitis, Allergic Contact |
|
Mercury |
3.90 | 16823706 |
| MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.85 | 16285004 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.68 | 17107852 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.55 | 19279558 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
sodium arsenate |
6.48 | 18186108 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
6.48 | 15131321 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.48 | 20420201 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.82 | 11462148 |
| MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.51 | 18367378 |
| MESH:D004487 |
Edema |
|
Arachidonic Acid |
7.38 | 9599246 11698051 9831321 7990266 16716910 15177302 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.38 | 12711302 11000095 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.04 | 18230668 15322242 16714409 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.26 | 12538720 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
9.26 | 19031437 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.10 | 17893378 20544844 19155303 16202921 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.10 | 9294722 10568697 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
19.46 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
19.46 | 17967931 18296743 19004024 19551842 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
19.46 | 15345470 |
| MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
19.46 | 19224547 14986274 |
| MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.28 | 16709447 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.56 | 11858732 |
| MESH:D005334 |
Fever |
|
Arachidonic Acid |
4.73 | 11852909 |
| MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.64 | 14745880 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.30 | 19069698 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
15.35 | 12168785 12639820 |
| MESH:D005355 |
Fibrosis |
|
Dietary Fats |
15.35 | 18296743 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
15.35 | 20067830 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.34 | 8708960 |
| MESH:D018149 |
Glucose Intolerance |
|
sodium arsenate |
5.17 | 19446573 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.73 | 10696789 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.37 | 11294989 10048152 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.54 | 15720958 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.42 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.00 | 16120746 15340226 12621046 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.18 | 15340226 18606429 8697196 16354765 16959395 |
| MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.67 | 21332399 |
| MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.70 | 21332399 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.04 | 10903974 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.04 | 18670907 18850075 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.91 | 16569931 16945680 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.55 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.54 | 17937319 |
| MESH:D007249 |
Inflammation |
|
Arachidonic Acid |
12.34 | 15177302 17371808 9831321 |
| MESH:D007249 |
Inflammation |
|
Dietary Fats |
12.34 | 20412841 |
| MESH:D007249 |
Inflammation |
|
Tamoxifen |
12.34 | 19457130 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
12.34 | 12200463 12878042 |
| MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
7.66 | 18457598 11836018 |
| MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
7.66 | 14714311 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.42 | 16580747 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.58 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.44 | 18776723 10903974 8314463 |
| MESH:D007674 |
Kidney Diseases |
|
Mercury |
6.44 | 17934191 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.53 | 12371664 |
| MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
7.53 | 18625569 |
| MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.21 | 15342952 17567588 |
| MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.92 | 18296743 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.30 | 18564211 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.30 | 12878042 |
| MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
4.49 | 16684651 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.49 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.15 | 12151625 |
| MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.27 | 18625569 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.27 | 11884234 19555203 |
| MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.15 | 14737004 |
| MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.88 | 19428831 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.67 | 14580682 19196723 16827153 11731420 19196722 |
| MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.68 | 19453300 |
| MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.89 | 19393235 12393984 |
| MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.30 | 15990972 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.92 | 16801185 |
| MESH:D009139 |
Musculoskeletal Abnormalities |
|
sodium arsenate |
4.94 | 18186108 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.08 | 12213967 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.57 | 19393235 |
| MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.54 | 19410462 |
| MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.13 | 19189210 19200415 19196722 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.58 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.36 | 19348381 18481113 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.31 | 14600291 |
| MESH:D009436 |
Neural Tube Defects |
|
sodium arsenate |
4.01 | 11749123 18186108 19446573 10525206 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Oxidopamine |
4.83 | 18514411 |
| MESH:D009765 |
Obesity |
|
Dietary Fats |
2.30 | 17217161 19632207 20132043 18674790 21332399 18457598 20518802 16723640 11836018 |
| MESH:D010051 |
Ovarian Neoplasms |
|
CD 437 |
3.34 | 17474084 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.77 | 11578682 |
| MESH:D010302 |
Parkinson Disease, Secondary |
|
Oxidopamine |
5.56 | 11771942 15893579 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.38 | 12520081 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.65 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.29 | 12371664 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.31 | 11399792 11222880 11896295 11118676 |
| MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 17013881 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.27 | 18760546 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.27 | 15067354 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.43 | 16919318 15861022 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.25 | 16882103 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.93 | 18990726 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.08 | 16192470 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
12.01 | 16709447 |
| MESH:D013088 |
Spermatocele |
|
Tamoxifen |
12.01 | 16709447 |
| MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.15 | 19457130 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.71 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.22 | 15669648 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.04 | 12697716 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
CD 437 |
5.54 | 16720286 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
5.54 | 16712894 17572228 8653321 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.39 | 14692618 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.12 | 1336536 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.73 | 12125929 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.62 | 14671159 15869587 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.38 | 15886252 |
| MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.81 | 16723640 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.58 | 17120751 |